![]() |
Volumn 8, Issue 2, 2002, Pages 139-145
|
The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE;
1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE;
2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN;
2 DIPROPYLAMINO 8 HYDROXYTETRALIN;
8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE;
ANXIOLYTIC AGENT;
BUSPIRONE;
CHOLINESTERASE INHIBITOR;
DIZOCILPINE;
GEPIRONE;
GLUTAMATE RECEPTOR ANTAGONIST;
IPSAPIRONE;
MK 108;
N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE;
NEUROTOXIN;
NICOTINE;
NOOTROPIC AGENT;
PINDOLOL;
ROBALZOTAN;
S UH 301;
SAPORIN;
SCOPOLAMINE;
SEROTONIN 1A AGONIST;
SEROTONIN 1A ANTAGONIST;
SEROTONIN 1A RECEPTOR;
SEROTONIN ANTAGONIST;
SPIPERONE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WAY 405;
ALZHEIMER DISEASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANXIETY NEUROSIS;
ARTICLE;
BRAIN FUNCTION;
COGNITION;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
DRUG ACTIVITY;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG MECHANISM;
DRUG WITHDRAWAL;
HYPOTHESIS;
MENTAL DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR BLOCKING;
SCHIZOPHRENIA;
SIGNAL TRANSDUCTION;
SYNAPTIC TRANSMISSION;
ALZHEIMER DISEASE;
ANIMALS;
COGNITION DISORDERS;
HUMANS;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT1;
SEROTONIN ANTAGONISTS;
|
EID: 0036233946
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612023396483 Document Type: Article |
Times cited : (96)
|
References (66)
|